Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Index Rebalance

<ul>
<li>The S&amp;P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.</li>
<li>In this insight, we take a look at the upcoming constituent changes in the run up to the September 2024 index rebal event.</li>
<li>We expect two regular changes in September 2024. There are also several live M&amp;A events which could trigger intra-review index changes in the late-2024/early-2025.</li>
</ul>


The S&amp;P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.
In this insight, we take a look at the upcoming constituent changes in the run up to the September 2024 index rebal event.
We expect two regular changes in September 2024. There are also several live M&amp;A events which could trigger intra-review index changes in the late-2024/early-2025.


Quiddity Leaderboard S&P500 Sep 24 Rebal: Palantir, Apollo, Workday Racing for Mega$ Flows

Equity Research Focusing on the Consumer Sector, Small Cap Consumer Research

Small Cap Consumer Research

Equity Research Focusing on the Consumer Sector

Small Cap Consumer Research, LLC is a leading company-sponsored equity research provider focusing on the consumer sector (apparel, brand licensing and specialty retailing segments).

Equity Bottom-Up

<ul><li>We are reiterating our Buy rating, $40 price target and projections for Regis as we look forward to 2024.</li><li>Further, we believe management's current strategic review will, at least, extend current debt maturities and could, potentially, re-equitize and delever the balance sheets.</li><li>Finally, we believe there remains the potential to begin to once again focus on growing the franchise base after another round of reducing low value franchises in 1H24.</li></ul>

We are reiterating our Buy rating, $40 price target and projections for Regis as we look forward to 2024.Further, we believe management's current strategic review will, at least, extend current debt maturities and could, potentially, re-equitize and delever the balance sheets.Finally, we believe there remains the potential to begin to once again focus on growing the franchise base after another round of reducing low value franchises in 1H24.

RGS: 2024 Signposts: Taking the Next Steps; Reiterate Buy, Price Target

<ul><li>We are reiterating our Buy rating, $2 price target and projections for Regis after the company announced a one for twenty reverse stock split.</li><li>We believe the reverse stock split, which will allow RGS to regain compliance with the NYSE Minimum Bid Price Requirements, is the first step in the company's strategic alternatives review, which, we believe, could also include deleveraging the balance sheet and placing the company on a stronger financial footing and prepared to register franchisee driven growth.</li><li>As such, we are reiterating our Buy rating asnd $2 price targt for RGS.</li></ul>

We are reiterating our Buy rating, $2 price target and projections for Regis after the company announced a one for twenty reverse stock split.We believe the reverse stock split, which will allow RGS to regain compliance with the NYSE Minimum Bid Price Requirements, is the first step in the company's strategic alternatives review, which, we believe, could also include deleveraging the balance sheet and placing the company on a stronger financial footing and prepared to register franchisee driven growth.As such, we are reiterating our Buy rating asnd $2 price targt for RGS.

RGS: Announces 1 for 20 Reverse Stock Split; 1st Step in Strategic Review

<ul><li>We are reiterating our Buy rating and updating our projections and price target to reflect the 1 for 20 RGS reverse stock split, which was completed yesterday.</li><li>We continue to view this action as the first step in the company's recently announced strategic review; we note the reverse stock split will allow RGS to regain compliance with the NYSE Minimum Bid Price Requirements.</li><li>We reiterate our Buy rating and now $40 price target for RGS.</li></ul>

We are reiterating our Buy rating and updating our projections and price target to reflect the 1 for 20 RGS reverse stock split, which was completed yesterday.We continue to view this action as the first step in the company's recently announced strategic review; we note the reverse stock split will allow RGS to regain compliance with the NYSE Minimum Bid Price Requirements.We reiterate our Buy rating and now $40 price target for RGS.

RGS: Updating Model for Reverse Stock Split; Reiterate Buy Rating

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>Market dynamics have deteriorated and are now much more mixed overall. Deteriorating signals include RS improvement for defensive Sectors, RS deterioration for small-caps, and the US dollar breaking above 92. Despite this mild deterioration in market dynamics, there are plenty of indicators that remain positive. This tells us any weakness should be treated as a buying opportunity and our outlook remains constructive for the months ahead.</p>

Market dynamics have deteriorated and are now much more mixed overall. Deteriorating signals include RS improvement for defensive Sectors, RS deterioration for small-caps, and the US dollar breaking above 92. Despite this mild deterioration in market dynamics, there are plenty of indicators that remain positive. This tells us any weakness should be treated as a buying opportunity and our outlook remains constructive for the months ahead.

United States

Bath & Body Works, Inc. manufactures personal care products. The Company offers fragrance, gifts, body care, and bath products. Bath & Body Works serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bath & Body Works (BBWI US)

Quiddity Leaderboard S&P500 Sep 24 Rebal: Palantir, Apollo, Workday Racing for Mega$ Flows

S&P500 rebals are notoriously difficult to predict because of significant index committee discretion. Sep24 could see two adds, two deletes. Q4...

Travis Lundy

RGS: 2024 Signposts: Taking the Next Steps; Reiterate Buy, Price Target

We are reiterating our Buy rating, $40 price target and projections for Regis as we look forward to 2024. Further, we believe management's current...

Small Cap Consumer Research

RGS: Announces 1 for 20 Reverse Stock Split; 1st Step in Strategic Review

We are reiterating our Buy rating, $2 price target and projections for Regis after the company announced a one for twenty reverse stock split. We...

Small Cap Consumer Research

RGS: Updating Model for Reverse Stock Split; Reiterate Buy Rating

We are reiterating our Buy rating and updating our projections and price target to reflect the 1 for 20 RGS reverse stock split, which was...

Small Cap Consumer Research

Upgrading U.S. Staples To Market Weight

Despite mild deterioration in market dynamics, there are plenty of indicators that remain positive and our outlook remains constructive for the...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)